Sequential Integrated Screen, Part 2 (NY) QMSCR2

Method(s) Chemiliuminescence (CL), Immunoassay (IA)
Components AFP, Unconjugated Estriol, hCG, Dimeric Inhibin A, PAPP-A (Pregnancy-associated Plasma Protein) and hCG from Maternal Serum Sequential Integrated Screen, Part 1; Interpretation
Specimen Required
Collect

One 5 mL gold (SST) top tube.

Transport

3 mL serum ambient (Min: 1 mL).

* Collection Instructions *

  • Collect between 14.0 to 22.9 weeks.
  • Maternal date of birth (mm/dd/yy), Estimated Date of Delivery by US/LMP/PE, weight, race, insulin-dependent diabetes status, repeat same (Y/N), number of fetuses, and neural tube defect history must be provided for interpretation of results.
  • Must complete patient demographic information using the Maternal Serum Screen Requisition.

Additional information: NT measurement, when provided by the physician, will be used for additional information.

Stability

Ambient: 14 days

Refrigerated: 14 days

Frozen: 28 days

Unacceptable Conditions
  • Gross hemolysis
  • Grossly lipemic
CPTCode 81511
Notes Performing Laboratory-Quest Diagnostics Nichols Institute-San Juan Capistrano, CA
Preferred Specimen Collection Device(s)
No Appointment Necessary
Show All Locations >
12 Patient Service Centers in Central New York.

Test Directory

A B C D E F
G H I J K L
M N O P Q R
S T U V W X
Y Z # List >